Cargando…

FLT3LG and IFITM3P6 consolidate T cell activity in the bone marrow microenvironment and are prognostic factors in acute myelocytic leukemia

Acute myelocytic leukemia (AML) is a malignancy of the stem cell precursors of the myeloid lineage. CD4+ and CD8+ T cells play pivotal roles in influencing AML progression but are functionally suppressed in the bone marrow microenvironment. We aimed to find hub genes related to T cell exhaustion and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Haiyan, Wu, Meng, Xia, Hongping, Du, Songjie, Zhou, Guoren, Long, Guangfeng, Zhu, Yanan, Huang, Xu, Yang, Daheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445253/ https://www.ncbi.nlm.nih.gov/pubmed/36081495 http://dx.doi.org/10.3389/fimmu.2022.980911

Ejemplares similares

Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
por: Maiorova, Varvara, et al.
Publicado: (2023)

Granulocyte Colony-stimulating Factor-primed Bone Marrow: An Excellent Stem-cell Source for Transplantation in Acute Myelocytic Leukemia and Chronic Myelocytic Leukemia
por: Li, Yuhang, et al.
Publicado: (2015)

Natural Flt3Lg-Based Chimeric Antigen Receptor (Flt3-CAR) T Cells Successfully Target Flt3 on AML Cell Lines
por: Maiorova, Varvara, et al.
Publicado: (2021)

Priapism due to chronic myelocytic leukemia
por: Syarif, et al.
Publicado: (2021)

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
por: Pol, Jonathan G., et al.
Publicado: (2020)

Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration
por: chen, Lihua, et al.
Publicado: (2022)

Identification of DNA methylation prognostic signature of acute myelocytic leukemia
por: Zhang, Haiguo, et al.
Publicado: (2018)

Telomere Reduction of Specific Chromosome Translocation in Acute Myelocytic Leukemia
por: Takauchi, Katsuhiko, et al.
Publicado: (1994)

Isotretinoin is active in the initial management of acute pro-myelocytic leukemia
por: Alkhaldy, Husain Y., et al.
Publicado: (2020)

Acute Myelocytic Leukæmia
por: Elder, William, et al.
Publicado: (1904)

bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia
Publicado: (1985)

A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
por: Xiaoqiu, Wang, et al.
Publicado: (2016)

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
por: Nagai, Kozo, et al.
Publicado: (2018)

OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
por: Eisfelder, Bartholomew J., et al.
Publicado: (2021)

miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia
por: Zhang, Xuewu, et al.
Publicado: (2020)

Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
por: Chen, Fangli, et al.
Publicado: (2016)

Multiple mutations of IFITM3 are associated with COVID-19 susceptibilityregulation function of IFITM3 in COVID-19
por: Guo, Hongzhe, et al.
Publicado: (2023)

Application of log-linear model in inference on karyotypic evolution in chronic myelocytic leukemia.
por: Hashimoto, T, et al.
Publicado: (1990)

Acute myelocytic leukemia in a patient with hemophagocytic lymphohistiocytosis: A case report
por: ZHAO, DEFENG, et al.
Publicado: (2014)

Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
por: Zhang, Hao, et al.
Publicado: (2023)

A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo
por: Li, Xiaojin, et al.
Publicado: (2014)

DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells
por: Wu, Min, et al.
Publicado: (2016)

FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia
por: Fang, Douglas D., et al.
Publicado: (2021)

Antiviral Protection by IFITM3 In Vivo
por: Zani, Ashley, et al.
Publicado: (2018)

Malignancy and IFITM3: Friend or Foe?
por: Rajapaksa, Ushani S., et al.
Publicado: (2020)

Comparative analysis of the chicken IFITM locus by targeted genome sequencing reveals evolution of the locus and positive selection in IFITM1 and IFITM3
por: Bassano, Irene, et al.
Publicado: (2019)

Survey of Activated FLT3 Signaling in Leukemia
por: Gu, Ting-lei, et al.
Publicado: (2011)

The Biology and Targeting of FLT3 in Pediatric Leukemia
por: Annesley, Colleen E., et al.
Publicado: (2014)

FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018)

Quantitation of chemosensitivity in acute myelocytic leukaemia.
por: Lihou, M. G., et al.
Publicado: (1983)

A Case of Myelocytic Leukæmia with Complications
por: McCay, F., et al.
Publicado: (1935)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
por: Maiti, Abhishek, et al.
Publicado: (2021)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis
por: Gómez-Herranz, Maria, et al.
Publicado: (2019)

An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas.
por: Ghanei, Mostafa, et al.
Publicado: (2002)

c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia
Publicado: (1983)

Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institution.
por: Lee, K. H., et al.
Publicado: (1996)

EXTENSIVE CUTANEOUS MANIFESTATIONS: PRESENTING FEATURE OF CHRONIC MYELOCYTIC LEUKEMIA IN SECOND BLAST CRISIS
por: Singhal, Manish, et al.
Publicado: (2010)

Postinduction Supportive Care of Pediatric Acute Myelocytic Leukemia: Should Patients be Kept in the Hospital?
por: Inoue, Susumu, et al.
Publicado: (2014)

Successful resolution of hemophagocytic lymphohistiocytosis during the chemotherapy course of acute myelocytic leukemia with ruxolitinib
por: Song, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tse6c71dis4g6rr2c3sk75e045